214 related articles for article (PubMed ID: 15495072)
1. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.
Vale L; Cody J; Wallace S; Daly C; Campbell M; Grant A; Khan I; Donaldson C; Macleod A
Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD003963. PubMed ID: 15495072
[TBL] [Abstract][Full Text] [Related]
2. Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults.
Vale L; Cody J; Wallace S; Daly C; Campbell M; Grant A; Khan I; Donaldson C; MacLeod A
Cochrane Database Syst Rev; 2003; (1):CD003963. PubMed ID: 12535493
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
4. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.
Rabindranath KS; Adams J; Ali TZ; MacLeod AM; Vale L; Cody J; Wallace SA; Daly C
Cochrane Database Syst Rev; 2007 Apr; 2007(2):CD006515. PubMed ID: 17443624
[TBL] [Abstract][Full Text] [Related]
5. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage renal disease.
Daly C; Campbell M; Cody J; Grant A; Donaldson C; Vale L; Lawrence P; MacLeod A; Wallace S; Khan I
Cochrane Database Syst Rev; 2001; (2):CD003078. PubMed ID: 11406068
[TBL] [Abstract][Full Text] [Related]
6. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
7. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
Macleod AM; Campbell M; Cody JD; Daly C; Donaldson C; Grant A; Khan I; Rabindranath KS; Vale L; Wallace S
Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003234. PubMed ID: 16034894
[TBL] [Abstract][Full Text] [Related]
8. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Khan I; Vale L; Wallace S; Macleod A
Cochrane Database Syst Rev; 2005 Jul; (3):CD003895. PubMed ID: 16034913
[TBL] [Abstract][Full Text] [Related]
9. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease.
Daly C; Cody JD; Khan I; Rabindranath KS; Vale L; Wallace SA
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003078. PubMed ID: 25117423
[TBL] [Abstract][Full Text] [Related]
10. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Shrivastava R
Cochrane Database Syst Rev; 2004 Oct; (4):CD004289. PubMed ID: 15495097
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
[TBL] [Abstract][Full Text] [Related]
14. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Jul; (3):CD004289. PubMed ID: 19588351
[TBL] [Abstract][Full Text] [Related]
15. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD004289. PubMed ID: 19370598
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.
Zhang L; Zeng X; Fu P; Wu HM
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009120. PubMed ID: 24953826
[TBL] [Abstract][Full Text] [Related]
17. Home versus in-centre haemodialysis for end-stage kidney disease.
Palmer SC; Palmer AR; Craig JC; Johnson DW; Stroumza P; Frantzen L; Leal M; Hoischen S; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009535. PubMed ID: 25412074
[TBL] [Abstract][Full Text] [Related]
18. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
19. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease.
Strippoli GF; Navaneethan SD; Craig JC
Cochrane Database Syst Rev; 2006 Oct; (4):CD003967. PubMed ID: 17054191
[TBL] [Abstract][Full Text] [Related]
20. The impact of change of renal replacement therapy modality on sleep quality in patients with end-stage renal disease: a systematic review and meta-analysis.
Kennedy C; Ryan SA; Kane T; Costello RW; Conlon PJ
J Nephrol; 2018 Feb; 31(1):61-70. PubMed ID: 28573387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
